- Details
- Written by Reggie Kumar
- Category: Health News
Imperial, California - A team of UCLA researchers found that there are several parts of California where, in a high percentage of people with thyroid cancer, the disease is already at an advanced stage by the time it is diagnosed.
- Details
- Written by Emily Gersema
- Category: Health News
Los Angeles, California - A blood thinner known for serious drug interactions is linked to increased hospitalizations for falls, altered mental state and insulin shock for Medicare patients who also take some diabetes drugs, according to a new study.
- Details
- Written by Laura Bailey
- Category: Health News
Ann Arbor, Michigan - One out of every four dollars employers pay for health care is tied to unhealthy lifestyle choices or conditions like smoking, stress and obesity, despite the fact that most large employers have workplace wellness programs.
- Details
- Written by IVN
- Category: Health News
Atlanta, Georgia - A new report calls attention to cancer in people with mental illness, suggesting that healthcare system and societal factors are just as critical as individual lifestyle factors linked to smoking and obesity, that lead to health disparities among this group. The report appears early online in CA: A Cancer Journal for Clinicians.
- Details
- Written by American Heart Association
- Category: Health News
Dallas, Texas - Women with Type 2 diabetes are twice as likely to have coronary heart disease compared to men, and may also need more frequent and intense physical activity to lower their risk of having a heart attack or stroke, according to a new American Heart Association scientific statement published in the association’s journal Circulation.
- Details
- Written by IVN
- Category: Health News
San Antonio, Texas - Among patients with HER2-positive, metastatic breast cancer that had progressed despite treatment with two or more forms of HER2-targeted therapy (trastuzumab [Herceptin] and lapatinib [Tykerb]), median overall survival was increased for those treated with trastuzumab emtansine (T-DM1 [Kadcyla]) compared with those who received treatment of physician’s choice, according to results from the phase III TH3RESA clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held December 8–12.
Page 178 of 374
